Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stock Incentive Plan (Details Textual)

v3.24.2.u1
Note 5 - Stock Incentive Plan (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2022
Apr. 30, 2020
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Aug. 12, 2024
Aug. 05, 2024
Oct. 31, 2017
Apr. 30, 2016
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) [1]         78,592          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares) [2]         (0)          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value     $ 223,545   $ 223,545          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested     $ 7,746   $ 7,746          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 4.05   $ 4.05          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Outstanding, Weighted Average Exercise Price (in dollars per share)     4.42   4.42          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Outstanding, Weighted Average Exercise Price (in dollars per share)     $ 2.96   $ 2.96          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount     $ 2,200,000   $ 2,200,000          
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)         1 year 10 months 24 days          
Share-Based Payment Arrangement, Expense, Tax Benefit         $ 0          
General and Administrative Expense [Member]                    
Share-Based Payment Arrangement, Expense     156,822 $ 256,297 312,077 $ 500,634        
Research and Development Expense [Member]                    
Share-Based Payment Arrangement, Expense     $ 177,568 $ 216,999 $ 350,767 $ 448,871        
Vesting Monthly Over One Year [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         10,000          
Vesting 6/48ths on Six-months and 1/48th After [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         68,592          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) 5,100,000 3,100,000 5,100,000   5,100,000       1,600,000 700,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized (in shares) 2,000,000 1,500,000                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       0            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)         0          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)         29,973          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)         10 years 10 years        
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Officer [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         25,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)     $ 0.6146   $ 0.6146          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)         4 years          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         43,592          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)         4 years          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member] | Minimum [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)     0.651   $ 0.651          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member] | Non-officer Employees [Member] | Maximum [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)     0.679   $ 0.679          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Options Held [Member] | Share-Based Payment Arrangement, Option [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         10,000          
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price (in dollars per share)     $ 0.3402   $ 0.3402          
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month)         12 months          
Monopar Therapeutics Inc. 2016 Stock Incentive Plan [Member] | Subsequent Event [Member]                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)             1,420,000 7,100,000    
[1] 78,592 options vest as follows: options to purchase 10,000 shares of the Company’s common stock vest monthly over one year; options to purchase 68,592 shares of the Company's common stock vest 6/48ths on the six-month anniversary of vesting commencement date and 1/48th per month thereafter.
[2] There were no forfeitures during the six months ended June 30, 2024.